Cargando…
Systemic Neoadjuvant and Adjuvant Therapies in the Management of Hepatocellular Carcinoma—A Narrative Review
SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is the most common type of liver cancer, accounting for approximately 85–90% of all cases of liver cancer worldwide. The five-year tumor recurrence rate has been estimated to be 70% among patients who present with resectable disease and undergo resectio...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340217/ https://www.ncbi.nlm.nih.gov/pubmed/37444618 http://dx.doi.org/10.3390/cancers15133508 |